| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9860 |
| Human Intestinal Absorption | HIA+ | 0.9947 |
| Caco-2 Permeability | Caco2+ | 0.5265 |
| P-glycoprotein Substrate | Substrate | 0.6408 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8067 |
| Inhibitor | 0.8193 |
| Renal Organic Cation Transporter | Inhibitor | 0.5395 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7277 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7405 |
| CYP450 2D6 Substrate | Non-substrate | 0.7674 |
| CYP450 3A4 Substrate | Substrate | 0.6176 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.7515 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.6110 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7407 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5131 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.5249 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5272 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9737 |
| Inhibitor | 0.6931 |
| AMES Toxicity | Non AMES toxic | 0.7907 |
| Carcinogens | Non-carcinogens | 0.7639 |
| Fish Toxicity | High FHMT | 0.9045 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9638 |
| Honey Bee Toxicity | Low HBT | 0.8890 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.6504 |
| Carcinogenicity (Three-class) | Non-required | 0.6952 |